HCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALL – Targeted Oncology
Targeted OncologyHCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALLTargeted OncologyResults of an interim analysis from a small phase I trial presented at the 2018 American Society of Pediatric Hematology/Oncology Conference showed th… Continue reading
